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1693. In the past, many relatively simple electrophysiologic concepts were madeto seem complex because of the confusing and inconsistent terminologyused to describe them. For example, the terms nonuniform refractoriness,inhomogeneous recovery, nonuniform repolarization, dispersion of refrac-toriness, and desynchronized repolarization all refer to the same electro-physiologic abnormality. We are now facing a similar problem with atrial
fibrillation. Previously, atrial fibrillation could be treated within acceptable stan-
dards by physicians who possessed only a superficial understanding of the arrhyth-
mia itself because the only options for treatment were rhythm-control or rate-control
drugs. However, the recent introduction of surgical and catheter interventional
treatment for atrial fibrillation has changed the requirements for therapeutic com-
petence and, as a result, has generated the usual bewildering terminology that occurs
when an entity is poorly understood and has no accurate classification system.
The confusing terminology surrounding atrial fibrillation has resulted in faulty
concepts, unsound treatment schemes, and misleading claims regarding the results
of interventional therapy. This problem stems primarily from the vague meaning
and multiple uses of the term chronic. The descriptors paroxysmal and chronic have
traditionally been used to characterize atrial fibrillation clinically, although their
precise meaning has never been clarified. Most authors, including this one, have
used the term paroxysmal to denote episodic or intermittent atrial fibrillation and the
term chronic to denote continuous, unrelenting atrial fibrillation, both terms being
applied without regard to how long the patient had the fibrillation. Recently,
however, the term chronic has been used to describe atrial fibrillation of long
duration, regardless of whether the atrial fibrillation is intermittent or continuous.
Because chronic in other areas of medicine means long standing, it is under-
standable that the term has evolved to describe long-standing atrial fibrillation.
However, because chronic, when applied to atrial fibrillation, has traditionally
meant continuous, its new use has led to an unfortunate and potentially dangerous
confusion regarding the results of various types of interventional therapy. Moreover,
our cardiology colleagues have recently proposed a new classification system for
atrial fibrillation1 that includes the additional terms persistent and permanent,
which, unfortunately, do not describe unique electrophysiologic characteristics and
therefore only serve to cloud the issue further.
The optimal treatment of atrial fibrillation depends on a proper understanding of
the electrophysiologic basis of each of its clinical manifestations. It is fortuitous that
in the case of atrial fibrillation, both its clinical manifestation and its proper
interventional treatment are dictated by its underlying electrophysiology. Unfortu-
nately, accuracy in diagnosis and interventional treatment are impossible using
terms such as chronic, paroxysmal, persistent, and permanent to characterize atrial
fibrillation because these terms do not discriminate between the different types of
atrial fibrillation, and they also mean different things to different people. The
confusion in diagnosis (and therefore in the subsequent reporting of interventional
results) caused by this contemporary terminology can be illustrated in the following
hypothetical cases.
Suppose that a patient has had multiple, recurrent, self-terminating bouts of atrial
fibrillation for the past 25 years despite medical therapy and several unsuccessful
electrical cardioversion attempts. Is this chronic atrial fibrillation because it has been
present for a long time? Is it paroxysmal atrial fibrillation because it is intermittent
in nature? Is it persistent atrial fibrillation because it persists despite medical therapy
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and cardioversion? Is it permanent atrial fibrillation because
it is long standing and cannot be ablated by medicines or
cardioversion? Is the underlying electrophysiologic abnor-
mality in such a patient related to pulmonary vein triggers,
nonpulmonary vein triggers, pulmonary vein tachycardia,
electrical remodeling, and/or self-sustained atrial macro-
reentry? Is the proper interventional treatment for this pa-
tient simple pulmonary vein isolation, the maze procedure,
or something in between?
Conversely, suppose that a patient has had continuous,
unrelenting atrial fibrillation for the past 7 months despite
maximum medical therapy and several unsuccessful electri-
cal cardioversion attempts. Is the diagnosis chronic atrial
fibrillation because it is continuous? Is it persistent or per-
manent atrial fibrillation because it is resistant to medical
therapy and cardioversion? Is it short-term chronic atrial
fibrillation because it is both continuous and of relatively
short-term duration? What is the underlying electrophysi-
ologic abnormality in this patient and what should be the
treatment goal of an interventional cardiologist or arrhyth-
mia surgeon? Should the interventional-surgical approach
be different for this patient and the first one described
above?
The proper treatment of both of these patients begins
with an accurate diagnosis, one that is based on the under-
lying electrophysiology rather than on some arbitrary and
meaningless time scale relating to the duration of the ar-
rhythmia. It is important to understand that in the absence of
gross enlargement of the atria, the duration of atrial fibril-
lation has no effect whatsoever on the results of interven-
tional catheter or surgical treatment.
These problems can be solved by the institution of the
simple classification system that follows. This classification
defines both the clinical presentation and the electrophysi-
ologic basis of each type of atrial fibrillation and in turn
dictates the proper goal of interventional therapy, surgical
therapy, or both for any patient presenting with atrial fibril-
lation.
Clinical Presentation
Atrial fibrillation presents clinically in one of 2 ways. The
patient either has atrial fibrillation all of the time or not. If
the atrial fibrillation is present all of the time, it is by
definition continuous. If the atrial fibrillation is not present
all of the time, it is by definition intermittent. Therefore all
atrial fibrillation can be classified as either intermittent atrial
fibrillation or continuous atrial fibrillation.
This simple classification correctly implies that there is a
fundamental pathophysiologic difference in the atrial fibril-
lation of a patient who presents with intermittent episodes
and one who presents with continuous arrhythmia and that
all other differences in their atrial fibrillation are irrelevant
in terms of how they should be treated interventionally.
Indeed, the clinical presentations are different specifically
because the underlying electrophysiology is different. This
correlation explains why their interventional treatment must
also be different. Thus this classification system is accurate
clinically, electrophysiologically, and therapeutically, and
the terminology is simple, descriptive, accurate, and logical.
Moreover, the terms continuous and intermittent are not
only specific and uniformly understandable, but their mean-
ings are direct opposites (ie, they are each other’s ant-
onyms).
Figure 1. Induction of atrial fibrillation by a premature atrial beat
originating in the orifice of one of the pulmonary veins. These
triggers can be caused by microreentrant circuits that occur in
the transitional zone of cells as the pulmonary vein endothelium
transitions into the left atrial endocardium. However, it is most
likely that these triggers are automatic rather than reentrant
because recurrent atrial tachycardias are known to arise from
automatic foci in other parts of the atria.9 PAC, Premature atrial
beat.
Figure 2. Once induced, all atrial fibrillation is characterized by
the presence of multiple macroreentrant circuits in the atria. This
electrophysiologic basis of atrial fibrillation is unrelated to (1)
how or from where it was induced, (2) whether it is intermittent
or continuous, and (3) its duration.
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It is intuitive that atrial fibrillation that is intermittent has to
be induced repeatedly and thus requires a trigger to induce
each individual episode of atrial fibrillation. In 1998, Hais-
saguerre and colleagues2 suggested that this trigger is lo-
cated in the orifices of the pulmonary veins in approxi-
mately 90% of patients, although more recent studies have
suggested that Haissaguerre et al’s figure is much too high.3
Regardless of the true incidence of pulmonary vein triggers,
the resultant premature atrial beat originating within the
pulmonary vein discharges into the left atrium and induces
the formation of multiple macroreentrant circuits involving
both atria (Figure 1).4 The multiple macroreentrant circuits
cause the atria to quiver, a state we know as atrial fibrillation
(Figure 2).5
Once induced, the atrial fibrillation persists until the
macroreentrant circuits terminate spontaneously or are ter-
minated by drugs or interventional therapy. If the atrial
fibrillation terminates spontaneously, the patient automati-
cally reverts to normal sinus rhythm (Figure 3). Each sub-
sequent episode of atrial fibrillation then requires another
premature atrial beat to initiate the episode, with the trigger
again being the pulmonary veins in the majority of cases.
At least 10% of patients with intermittent atrial fibrilla-
tion have a triggering mechanism that does not involve the
pulmonary veins (Figure 4).2,3 It is well documented that
atrial fibrillation can be induced intermittently by the
Wolfe-Parkinson-White syndrome, atrioventricular node re-
entry, or deterioration of atrial flutter,5,6 but in most cases
these nonpulmonary vein triggers, like their counterparts in
the pulmonary veins, are simple automatic foci located
elsewhere in the atria.
Continuous Atrial Fibrillation
If normal sinus rhythm cannot be reestablished either spon-
taneously or with drugs, the atrial fibrillation will no longer
be episodic, and once induced, the atria will continue to
fibrillate indefinitely. This is by definition continuous atrial
fibrillation. Once atrial fibrillation becomes continuous, it
does not need a trigger to reinduce it repeatedly because the
atria are fibrillating all of the time. Thus continuous atrial
fibrillation does not depend on the pulmonary veins for
induction or perpetuation.
The reason that atrial fibrillation becomes continuous is
because the macroreentrant circuits in the atrial myocar-
dium have the ability to sustain themselves. Allessie7 has
attributed this to atrial remodeling. This is electrical remod-
eling and might or might not be associated with anatomic
remodeling (ie, with enlargement, hypertrophy, or stretch-
ing of the atria). The essence of this concept, as Allessie
points out, is that “atrial fibrillation begets atrial fibrilla-
Figure 3. Intermittent atrial fibrillation (see text for further discussion). NSR, Normal sinus rhythm; PAC, premature
atrial beat.
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tion.” In other words, the more a patient experiences atrial
fibrillation, the more that patient is likely to experience it
again.
Interventional Therapy
Simple pulmonary vein encirclement confines the trigger
mechanism for intermittent atrial fibrillation to the pulmo-
nary veins, and therefore if performed adequately, it will
cure the majority of patients with intermittent atrial fibril-
lation (Figure 5). Unfortunately, it is doomed to fail as an
isolation procedure in a significant number of patients with
intermittent atrial fibrillation because the trigger mechanism
is not in the pulmonary veins. In addition, because contin-
uous atrial fibrillation is not dependent on the pulmonary
Figure 4. The trigger for the induction of intermittent atrial fibrillation is located in the pulmonary veins in 90% of
patients and outside the pulmonary vein area in 10% of patients.
Figure 5. Pulmonary vein isolation for intermittent atrial fibrillation. Because the trigger resides within one or more
of the pulmonary veins in 90% of patients with intermittent atrial fibrillation, simple pulmonary vein encirclement
will cure 90% of these patients. However, 10% of patients with intermittent atrial fibrillation will not be cured with
simple pulmonary vein isolation. NSR, Normal sinus rhythm.
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veins for its maintenance, simple pulmonary vein encircle-
ment is not a logical treatment goal in patients with contin-
uous atrial fibrillation (Figure 6).
Thus in some patients with intermittent atrial fibrillation
and in all patients with continuous atrial fibrillation, simple
pulmonary vein encirclement is inadequate, and the goal
shifts from isolating the trigger to ablating the macroreen-
trant circuits that characterize atrial fibrillation. One way of
accomplishing the latter would be to “breadloaf” the atria,
but obviously that would destroy the function of the atria
postoperatively. Another way of precluding the possibility
of atrial macroreentry (and thus atrial fibrillation) would be
to excise enough of the atrial mass to make it too small to
sustain macroreentrant circuits, but again, its function post-
operatively would be destroyed. The only feasible way to
ablate the atrial macroreentry and at the same time leave the
resultant sinus rhythm capable of activating the entire atrial
myocardium to ensure postoperative atrial transport func-
tion is to perform either the maze procedure or some variant
thereof. The maze procedure is a classic ablation procedure
in that it abolishes the macroreentry responsible for atrial
fibrillation. Its lesion patterns are complex only because of
the requirement that it not destroy postoperative atrial trans-
port function.
Observations that Modify the Rules
The above discussion can be simplified to the following
rules:
1. The objective of interventional-surgical treatment in
the majority of patients with intermittent atrial fibril-
lation is to isolate the inducing trigger or triggers to
the pulmonary veins.
2. The objective of interventional-surgical treatment in
patients with continuous atrial fibrillation is to ablate
the macroreentrant circuits responsible for its
maintenance.
As with all rules and classifications, there are occasional
exceptions that can aggravate the level of confusion. For
example, one clinical observation that is problematic for the
simple classification and treatment regimen outlined above
is that pulmonary vein isolation alone does occasionally
cure continuous atrial fibrillation. The principles described
above would suggest that to be impossible.
Because of the confusion involving the meaning of the
term chronic, as discussed above, it is impossible to know
exactly how many patients with continuous atrial fibrillation
have been cured by means of pulmonary vein encirclement
alone, although it is clear that the total number is relatively
small. Nevertheless, in view of the known electrophysiol-
ogy described above, a legitimate question to raise is how
simple pulmonary vein encirclement can ever cure a patient
with continuous atrial fibrillation. There would seem to be 2
plausible explanations.
First, if an unusually large area of the atrial cuff is
included within the pulmonary vein encircling incision, so
much of the left atrium might be isolated that all of the
functional macroreentrant circuits in the left atrium of that
particular patient might be inadvertently interrupted or iso-
lated. This physiology is equivalent to that occurring with
excision of a large portion of the left atrium. The problem
with this seemingly fortuitous scenario is the risk that so
much of the left atrium will be isolated that the remaining
left atrial function might be essentially destroyed.
Second, it has recently been suggested that in some
patients the triggers in the pulmonary veins might fire
incessantly, thereby continuously triggering the atrial fibril-
lation so that every time the arrhythmia tries to break, it is
immediately reinduced.8,9 Therefore despite having the
Figure 6. Failure of pulmonary vein isolation in patients with continuous atrial fibrillation. Because the mainte-
nance of continuous atrial fibrillation is not dependent on induction triggers in the pulmonary veins, simple
pulmonary vein isolation in these patients is not scientifically sound as an interventional-surgical approach to
treatment.
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physiology of intermittent atrial fibrillation, this scenario
would produce the clinical picture of continuous atrial fi-
brillation, but it would be curable by means of simple
pulmonary vein isolation. Because continuous rapid firing
of an automatic ectopic focus has been documented to occur
in other parts of the left atrium, it is reasonable to suspect
that it might occur in the region of the pulmonary vein
orifices as well. If such an incessant trigger constantly
precluded the patient from converting to sinus rhythm for
more than 1 or 2 beats and if it were present within or near
the orifices of the pulmonary veins, then pulmonary vein
encirclement would cure this particular case of continuous
atrial fibrillation.
Although the first scenario likely occurs clinically, there
is little reason to believe that the second scenario occurs
with any significant frequency. In 35 years of experience
with operations for all types of cardiac arrhythmias, the
author has encountered only one patient with long-standing,
unrelenting, continuous rapid firing of an atrial ectopic
focus, that occurring in the left atrial appendage of a 14
year-old boy.4 This incessant firing of the automatic focus
did not cause atrial fibrillation in that patient but rather
produced a rapid (200 beats/min) regular atrial tachycardia
that remained unabated for 4 years until it was surgically
terminated by means of cryoablating the trigger at the tip of
the left atrial appendage. The rarity, indeed the virtual
absence clinically, of this type of continuous trigger mech-
anism elsewhere in either atrium makes it extremely un-
likely that it would occur in or around the pulmonary veins.
In addition, unless the substrate already exists for the main-
tenance of macroreentry within the atria, there is no reason
to believe that such pulmonary vein tachycardia would
cause atrial fibrillation rather than a rapid regular atrial
tachycardia. Indeed, the reports of this pulmonary vein
tachycardia describe bursts of rapid tachycardia within the
pulmonary veins rather than the incessant, unrelenting trig-
ger that would be necessary to make physiologic intermit-
tent atrial fibrillation present clinically as continuous atrial
fibrillation. Thus even though simple encirclement of the
pulmonary veins in patients with continuous atrial fibrilla-
tion might occasionally inadvertently cure the problem, it is
not a scientifically sound surgical-interventional approach
in such patients.
The Rationale for Future Interventional Therapy
Although predicting the future is always perilous, enough
facts are available to know that the clinical spectrum of
atrial fibrillation is destined to change in the coming years.
Of the approximately 3000 patients with atrial fibrillation
whom the author personally interviewed over the past 20
years, approximately one half had intermittent atrial fibril-
lation, and one half had continuous atrial fibrillation. Those
patients fell into the following historical categories.
Patients presenting with intermittent atrial fibrillation
(approximately 50% of the total) were defined as patients
who had experienced only intermittent atrial fibrillation
Patients presenting with continuous atrial fibrillation (ap-
proximately 50% of the total) were defined as patients who
had intermittent atrial fibrillation initially that eventually
deteriorated into continuous atrial fibrillation and patients
who converted from normal sinus rhythm directly into con-
tinuous atrial fibrillation without a transition period of in-
termittent atrial fibrillation.
Among the roughly 50% of patients who presented in
continuous atrial fibrillation, virtually all had experienced
intermittent atrial fibrillation at some earlier point in their
lives. As mentioned above, this evolution from intermittent
to continuous atrial fibrillation occurs because of the phe-
nomenon of atrial remodeling, in which the more a patient
experiences atrial fibrillation, the more that patient is likely
to experience it again.
In view of this observation, it seems apparent that as
surgeons and interventional cardiologists become more ag-
gressive and successful in treating intermittent atrial fibril-
lation, progressively fewer patients will ultimately be al-
lowed to have continuous atrial fibrillation. Thus it follows
that in the future, most patients who present for atrial
fibrillation treatment will have the intermittent type, the
majority of which is amenable to simple pulmonary vein
isolation procedures. Nevertheless, it would seem that the
ultimate goal of interventional-surgical therapy should be to
cure all patients with atrial fibrillation, including those with
enlarged atria, thickened atrial walls, or both and those with
associated cardiac disease. The attainment of that goal re-
quires a better understanding of the problem, more accurate
reporting of results, and a diversified armamentarium of
procedures, all of which must be based on sound scientific
and surgical principles.
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